JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luker, G. D.
Right arrow Articles by Piwnica-Worms, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luker, G. D.
Right arrow Articles by Piwnica-Worms, D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 11, 6979-6991, March 12, 1999

Multidrug Resistance (MDR1) P-glycoprotein Enhances Esterification of Plasma Membrane Cholesterol

Gary D. LukerDagger §, Kent R. Nilsson§, Douglas F. Covey§, and David Piwnica-WormsDagger §

From the Dagger  Laboratory of Molecular Radiopharmacology, Mallinckrodt Institute of Radiology and the § Department of Molecular Biology and Pharmacology, Washington University Medical School, St. Louis, Missouri 63110

Class I P-glycoproteins (Pgp) confer multidrug resistance in tumors, but the physiologic function of Pgp in normal tissues remains uncertain. In cells derived from tissues that normally express Pgp, recent data suggest a possible role for Pgp in cholesterol trafficking from the plasma membrane to the endoplasmic reticulum. We investigated the esterification of plasma membrane cholesterol under basal conditions and in response to sphingomyelinase treatment in transfected and drug-selected cell lines expressing differing amounts of functional class I Pgp. Compared with parental NIH 3T3 fibroblasts, cells transfected with human multidrug resistance (MDR1) Pgp esterified more cholesterol both without and with sphingomyelinase. Esterification also was greater in drug-selected Dox 6 myeloma cells than parental 8226 cells, which express low and non-immunodetectable amounts of Pgp, respectively. However, no differences in total plasma membrane cholesterol were detected. Transfection of fibroblasts with the multidrug resistance-associated protein (MRP) did not alter esterification, showing that cholesterol trafficking was not generally affected by ATP-binding cassette transporters. Steroidal (progesterone, dehydroepiandrosterone) and non-steroidal antagonists (verapamil, PSC 833, LY335979, and GF120918) were evaluated for effects on both cholesterol trafficking and the net content of 99mTc-Sestamibi, a reporter of drug transport activity mediated by Pgp. In Pgp-expressing cells treated with nonselective and selective inhibitors, both the kinetics and efficacy of inhibition of cholesterol esterification differed from the antagonism of drug transport mediated by Pgp. Thus, although the data show that greater expression of class I Pgp within a given cell type is associated with enhanced esterification of plasma membrane cholesterol in support of a physiologic function for Pgp in facilitating cholesterol trafficking, the molecular mechanism is dissociated from the conventional drug transport activity of Pgp.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. F. De Rosa, C. Ackerley, B. Wang, S. Ito, D. M. Clarke, and C. Lingwood
Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog
J. Biol. Chem., February 22, 2008; 283(8): 4501 - 4511.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
W. Le Goff, M. Settle, D. J. Greene, R. E. Morton, and J. D. Smith
Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis
J. Lipid Res., January 1, 2006; 47(1): 51 - 58.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
V. Sharma, J. L. Prior, M. G. Belinsky, G. D. Kruh, and D. Piwnica-Worms
Characterization of a 67Ga/68Ga Radiopharmaceutical for SPECT and PET of MDR1 P-Glycoprotein Transport Activity In Vivo: Validation in Multidrug-Resistant Tumors and at the Blood-Brain Barrier
J. Nucl. Med., February 1, 2005; 46(2): 354 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
B. Bauer, A. M. S. Hartz, G. Fricker, and D. S. Miller
Modulation of p-Glycoprotein Transport Function at the Blood-Brain Barrier
Experimental Biology and Medicine, February 1, 2005; 230(2): 118 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
W. Le Goff, D.-Q. Peng, M. Settle, G. Brubaker, R. E. Morton, and J. D. Smith
Cyclosporin A Traps ABCA1 at the Plasma Membrane and Inhibits ABCA1-Mediated Lipid Efflux to Apolipoprotein A-I
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2155 - 2161.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Modok, C. Heyward, and R. Callaghan
P-glycoprotein retains function when reconstituted into a sphingolipid- and cholesterol-rich environment
J. Lipid Res., October 1, 2004; 45(10): 1910 - 1918.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Arora, J.-M. Yang, R. Utsumi, T. Okamoto, T. Kitayama, and W. N. Hait
P-Glycoprotein Mediates Resistance to Histidine Kinase Inhibitors
Mol. Pharmacol., September 1, 2004; 66(3): 460 - 467.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. F. De Rosa, D. Sillence, C. Ackerley, and C. Lingwood
Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis
J. Biol. Chem., February 27, 2004; 279(9): 7867 - 7876.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Higashi, H. Itabe, H. Fukase, M. Mori, Y. Fujimoto, and T. Takano
Transmembrane Lipid Transfer Is Crucial for Providing Neutral Lipids during Very Low Density Lipoprotein Assembly in Endoplasmic Reticulum
J. Biol. Chem., June 6, 2003; 278(24): 21450 - 21458.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. D. Luker, J. L. Dahlheimer, R. E. Ostlund Jr., and D. Piwnica-Worms
Decreased hepatic accumulation and enhanced esterification of cholesterol in mice deficient in mdr1a and mdr1b P-glycoproteins
J. Lipid Res., September 1, 2001; 42(9): 1389 - 1394.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Mistry, A. J. Stewart, W. Dangerfield, S. Okiji, C. Liddle, D. Bootle, J. A. Plumb, D. Templeton, and P. Charlton
In Vitro and in Vivo Reversal of P-Glycoprotein-mediated Multidrug Resistance by a Novel Potent Modulator, XR9576
Cancer Res., January 1, 2001; 61(2): 749 - 758.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. J. Newman, J. C. Rodarte, K. D. Benbatoul, S. J. Romano, C. Zhang, S. Krane, E. J. Moran, R. T. Uyeda, R. Dixon, E. S. Guns, et al.
Discovery and Characterization of OC144-093, a Novel Inhibitor of P-Glycoprotein-mediated Multidrug Resistance
Cancer Res., June 1, 2000; 60(11): 2964 - 2972.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Venkateswaran, J. J. Repa, J.-M. A. Lobaccaro, A. Bronson, D. J. Mangelsdorf, and P. A. Edwards
Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages. A TRANSCRIPTIONAL ROLE FOR SPECIFIC OXYSTEROLS
J. Biol. Chem., May 5, 2000; 275(19): 14700 - 14707.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. V. Rao, J. L. Dahlheimer, M. E. Bardgett, A. Z. Snyder, R. A. Finch, A. C. Sartorelli, and D. Piwnica-Worms
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
PNAS, March 30, 1999; 96(7): 3900 - 3905.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. W. Johnstone, K. M. Tainton, A. A. Ruefli, C. J. Froelich, L. Cerruti, S. M. Jane, and M. J. Smyth
P-glycoprotein Does Not Protect Cells against Cytolysis Induced by Pore-forming Proteins
J. Biol. Chem., May 11, 2001; 276(20): 16667 - 16673.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.